ZTS

NYSE Healthcare

Zoetis Inc. Class A Common Stock

Drug Manufacturers - Specialty & Generic

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

๐Ÿ“Š Market Data
Price$114.16
Volume2,543,944
Market Cap48.19B
Dividend Yield %1.84%
Beta0.970
RSI (14-Day)37.6
200-Day MA$131.09
50-Day MA$119.43
52-Week High$172.23
52-Week Low$112.97
P/E Ratio18.96
Forward P/E15.07
Price / Book14.56
๐ŸŽฏ Investment Strategy Scores

ZTS scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 66/100โ–ฒ +1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 73/100โ–ฒ +5
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 87/100โ–ฒ +3
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 12/100โ–ผ -7
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ‹ Institutional Whale (90/100) โ€” this strategy Large-cap, institutional-quality stocks.

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (12/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find ZTS in your text

Paste any article, transcript, or post โ€” the tool will extract ZTS and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.